Neoadjuvant camrelizumab plus chemotherapy for locally advanced cervical cancer (NACI study): A prospective, single-arm, phase II trial

被引：0
|
作者：
Chen, Jing
Li, Kezhen
Hu, Yingjie
Han, Yingyan
Shen, Yuanming
Wang, Yanzhou
Song, Kun
Xia, Bairong
Chen, Xiaojun
Zou, Dongling
Wang, Yingmei
Sun, Chaoyang
Chen, Gang
Ma, Ding
机构：
[1] Huazhong Univ Sci & Technol, Coll Med, Wuhan, Peoples R China
[2] Zhejiang Univ, Womens Hosp, Sch Med, Hangzhou, Zhejiang, Peoples R China
[3] Army Med Univ, Southwest Hosp, Chongqing, Peoples R China
[4] Shandong Univ, Qilu Hosp, Jinan, Peoples R China
[5] Univ Sci & Technol China, Affiliated Hosp 1 USTC, Div Life Sci & Med, Hefei, Peoples R China
[6] Univ Sci & Technol China, Div Life Sci & Med, Hefei, Peoples R China
[7] Fudan Univ, Obstet & Gynecol Hosp, Shanghai, Peoples R China
[8] Chongqing Univ, Gynecol Oncol Ctr, Canc Hosp, Chongqing, Peoples R China
[9] Tianjin Med Univ, Gen Hosp, Tianjin, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5520
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Neoadjuvant camrelizumab plus chemotherapy in patients with locally advanced cervical cancer (NACI): A prospective, single-arm, phase II trial
    Chen, J.
    Li, K.
    Han, Y.
    Shen, Y.
    Wang, Y.
    Song, K.
    Chen, X.
    Xia, B.
    Zou, D.
    Wang, Y.
    Ma, D.
    [J]. ANNALS OF ONCOLOGY, 2022, 33 (07) : S804 - S804
  • [2] Neoadjuvant camrelizumab plus chemotherapy for locally advanced cervical cancer (NACI Study): a study protocol of a prospective, single-arm, phase II trial
    Chen, Jing
    Han, Yingyan
    Hu, Yingjie
    Feng, Xue
    Meng, Xiaolin
    Guo, Shuaiqingying
    Sun, Chaoyang
    Chen, Gang
    Li, Kezhen
    [J]. BMJ OPEN, 2023, 13 (05):
  • [3] Neoadjuvant chemotherapy plus camrelizumab for locally advanced cervical cancer (NACI study): a multicentre, single-arm, phase 2 trial
    Li, Kezhen
    Chen, Jing
    Hu, Yingjie
    Wang, Yan-Zhou
    Shen, Yuanming
    Chen, Gang
    Peng, Wenju
    Fang, Zixuan
    Xia, Bairong
    Chen, Xiaojun
    Song, Kun
    Wang, Yingmei
    Zou, Dongling
    Wang, Yan-Chun
    Han, Yingyan
    Feng, Xue
    Yuan, Jing
    Guo, Shuaiqingying
    Meng, Xiaolin
    Feng, Chenzhao
    Chen, Yin
    Yang, Jie
    Fan, Junpeng
    Wang, Jianliu
    Ai, Jihui
    Ma, Ding
    Sun, Chaoyang
    [J]. LANCET ONCOLOGY, 2024, 25 (01): : 76 - 85
  • [4] Neoadjuvant camrelizumab plus chemotherapy in patients with locoregionally advanced nasopharyngeal carcinoma: A single-arm, phase II trial
    Gao, Jin
    Qian, Liting
    Zhou, Lingran
    Sun, Bin
    He, Jian
    Wang, Ru
    Zhang, Yangyang
    Yang, Liping
    Zhou, Yan
    Yang, Jing
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [5] CapOX as neoadjuvant chemotherapy for locally advanced operable colon cancer patients: a prospective single-arm phase II trial
    Liu, Fangqi
    Yang, Li
    Wu, Yuchen
    Li, Cong
    Zhao, Jiang
    Keranmu, Adili
    Zheng, Hongtu
    Huang, Dan
    Wang, Lei
    Tong, Tong
    Xu, Junyan
    Zhu, Ji
    Cai, Sanjun
    Xu, Ye
    [J]. CHINESE JOURNAL OF CANCER RESEARCH, 2016, 28 (06) : 589 - 597
  • [6] Camrelizumab and chemotherapy as neoadjuvant treatment for locally advanced esophageal squamous cell carcinoma (ESCC): A single-arm, phase II trial
    Gong, Lei
    Yang, Yueyang
    Zhang, Hongdian
    Qiao, Yufeng
    Wang, Haitong
    Ren, Peng
    Tang, Peng
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [7] Multicenter, single-arm, phase II trial of camrelizumab and chemotherapy as neoadjuvant treatment for locally advanced esophageal squamous cell carcinoma
    Liu, Jun
    Yang, Yang
    Liu, Zhichao
    Fu, Xiaolong
    Cai, Xiaoyue
    Li, Hongxuan
    Zhu, Li
    Shen, Yan
    Zhang, Hong
    Sun, Yifeng
    Chen, Hezhong
    Yu, Bentong
    Zhang, Renquan
    Shao, Jinchen
    Zhang, Ming
    Li, Zhigang
    [J]. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 (03)
  • [8] Camrelizumab plus concurrent chemoradiotherapy for locally advanced cervical cancer: Preliminary results of a single-arm, open-label, phase II trial
    Xiao, Y.
    Cheng, H.
    Wang, L.
    Yang, L.
    Yu, X.
    [J]. ANNALS OF ONCOLOGY, 2022, 33 (07) : S805 - S805
  • [9] CapOX as neoadjuvant chemotherapy for locally advanced operable colon cancer patients: a prospective single-arm phase Ⅱ trial
    Fangqi Liu
    Li Yang
    Yuchen Wu
    Cong Li
    Jiang Zhao
    Adili Keranmu
    Hongtu Zheng
    Dan Huang
    Lei Wang
    Tong Tong
    Junyan Xu
    Ji Zhu
    Sanjun Cai
    Ye Xu
    [J]. Chinese Journal of Cancer Research, 2016, 28 (06) : 589 - 597
  • [10] Intensive cycles of neoadjuvant camrelizumab combined with chemotherapy in locally advanced esophageal squamous cell carcinoma: a single-arm, phase II trial
    Yang, Guozhen
    Su, Xiaodong
    Huang, Yuanheng
    Luo, Guangyu
    Wang, Zhiqiang
    Cai, Peiqiang
    Zheng, Yating
    Bei, Ting
    Huang, Mengli
    Bai, Yuezong
    He, Haoqiang
    Xiang, Jin
    Cai, Muyan
    Zhong, Jiudi
    Guo, Qiyu
    Zhang, Xu
    [J]. JOURNAL OF TRANSLATIONAL MEDICINE, 2023, 21 (01)
12345